IMMP Wutah bathi EPS kuartalan Immutep

Logo grafis Immutep Limited (IMMP)

The quarterly EPS percentage change on GURU.Markets reflects dynamics amid a neutral geopolitical backdrop, with the parameter stabilizing at 3.50. Biotech company Immutep Limited (IMMP) is developing innovative LAG-3 therapy to combat solid tumors. Management is effectively expanding strategic collaboration with global pharma behemoths, confirming the uniqueness of its scientific research.

Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan immutep.com (IMMP): kanggo periode 04.07.2022 - 12.11.2026

Rincian analitis lan laporan data perusahaan Immutep Corp (IMMP)

- nilai pasar lan prakiraan target analis:
Bagan rega Immutep|IMMP - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar Immutep Limited ADR|IMMP - Total Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Aset Bersih saben Siji Saham Immutep|IMMP - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku immutep.com|IMMP - Gunggung Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Immutep Limited|IMMP - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Immutep Limited|IMMP - Gunggung utang perusahaan|Utang marang nilai buku Immutep Limited ADR|IMMP - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Immutep|Rasio cepet immutep.com
- rincian bathi lan kelipatan pasar:
IMMP - Penghasilan resik perusahaan|Bathi sing dikarepake Immutep Limited|IMMP - Kapitalisasi marang bathi resik|Prakiraan rega marang bathi Immutep Limited ADR|IMMP - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Immutep Limited ADR|IMMP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Immutep|IMMP - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan immutep.com|IMMP - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Immutep Limited
Analisis dhasar perusahaan:Immutep, IMMP
Produk asil prodhuksi Immutep Limited

For Immutep Limited (IMMP), this indicator serves as a tool to assess the scaling efficiency of its oncology pipeline. The calculation is based on the percentage change in net earnings per share between the current and previous quarters. By analyzing the growth rate of quarterly earnings per share, an investor determines the sustainability of the financial result. For the biotechnology sector, such price action confirms the success of clinical trials. Stable growth indicates the viability of the global expansion strategy.

Analisis pesaing

Merus (MRUS) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Anixa Biosciences|ATOS (Atossa) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Context Tx CNTX|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Mersana Therapeutics (MRSN)|briacell.com - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan EPIX (ESSA Pharma)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan QT Imaging Holdings (QTI)